glp-1 food news Friendly: How Big is trying to leverage the GLP-1 weight loss drug fad Big Food Is Learning to
Description
For weight management, NICE (TA875) recommends semaglutide 2.4 mg (Wegovy) only within specialist weight management services for adults with a BMI of at least 35 kg/m (or 30 kg/m with weight-related comorbidities) and as part of a supervised programme for a maximum of 2 years
A low eGFR indicates reduced kidney function, which may be due to chronic kidney disease, acute kidney injury, or conditions such as diabetes, high blood pressure, or urinary tract obstruction

Accessed October 9, 2025

The goal is not to cook less and eat worse
A shift like this would trickle down to improvements in commercial insurance coverage, placing pressure on other payers and potentially stimulating a reevaluation of coverage and restrictions across the board
Can a patch deliver GLP-1 medication through skin
